Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review

In recent years, GLP-1 receptor agonists (GLP-1RA), and SGLT-2 inhibitors (SGLT-2i) have become available, which have become valuable additions to therapy for type 2 diabetes as they are associated with low risk for hypoglycemia and cardiovascular benefits. Indeed, SGLT-2i have emerged as a promisin...

Descripción completa

Detalles Bibliográficos
Autores principales: Panico, Cristina, Bonora, Benedetta, Camera, Antonella, Chilelli, Nino Cristiano, Prato, Giuliana Da, Favacchio, Giuseppe, Grancini, Valeria, Resi, Veronica, Rondinelli, Maurizio, Zarra, Emanuela, Pintaudi, Basilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314539/
https://www.ncbi.nlm.nih.gov/pubmed/37391739
http://dx.doi.org/10.1186/s12933-023-01855-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314539/
https://www.ncbi.nlm.nih.gov/pubmed/37391739
http://dx.doi.org/10.1186/s12933-023-01855-y

Ejemplares similares